user

The Impact of Cardiovascular Risk, Baseline LDL-Cholesterol, Treatment Dose and Adherence on Cost-Effectiveness of Statins in Newly Diagnosed Diabetes Patients

被引：0
|
作者：
de Vries, Dianna [1 ]
Hak, Eelko [1 ]
Postma, Maarten J. [1 ]
机构：
[1] Univ Groningen, PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
63
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [31] Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk
    Kohli-Lynch, Ciaran N.
    Bellows, Brandon K.
    Thanassoulis, George
    Zhang, Yiyi
    Pletcher, Mark J.
    Vittinghoff, Eric
    Pencina, Michael J.
    Kazi, Dhruv
    Sniderman, Allan D.
    Moran, Andrew E.
    JAMA CARDIOLOGY, 2019, 4 (10) : 969 - 977
  • [32] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AT HIGH CARDIOVASCULAR RISK IN POLAND
    Pawlik, D.
    Wojcik, R.
    Zawodnik, A.
    Kaczor, M. P.
    VALUE IN HEALTH, 2017, 20 (09) : A478 - A478
  • [33] Left ventricular hypertrophy and cardiovascular risk stratification: Impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives
    Meani, S.
    Cuspidi, C.
    Valerio, C.
    Fusi, V.
    Sala, C.
    Zanchetti, A.
    JOURNAL OF HYPERTENSION, 2006, 24 : S57 - S57
  • [34] Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives
    Cuspidi, Cesare
    Meani, Stefano
    Valerio, Cristiana
    Fusi, Veronica
    Sala, Carla
    Zanchetti, Alberto
    JOURNAL OF HYPERTENSION, 2006, 24 (08) : 1671 - 1677
  • [35] Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain
    Peral, Carmen
    Sanchez-Ballester, Francisco
    Garcia-Mediero, Jose M.
    Ramos, Jaime
    Rejas, Javier
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 541 - 550
  • [36] Impact of diabetes on LDL-cholesterol target achievement in patients with cardiovascular disease in clinical practice in Europe and Canada: results of the dyslipidemia international study
    Gitt, A. K.
    Leiter, L.
    Lundman, P.
    Drexel, H.
    Ferrieres, J.
    Gonzalez-Juanatey, J. R.
    Pedersen, T.
    Thomsen, K. K.
    Wood, D.
    Kastelein, J. P.
    EUROPEAN HEART JOURNAL, 2011, 32 : 227 - 227
  • [37] MODELING THE COST-EFFECTIVENESS OF ILAPRAZOLE VS. OMEPRAZOLE FOR THE TREATMENT OF NEWLY DIAGNOSED DUODENAL ULCER PATIENTS IN CHINA
    Lu, Y. J.
    Xu, G. X.
    Lu, W. Q.
    Liu, Z.
    Song, R. L.
    Xuan, J.
    VALUE IN HEALTH, 2015, 18 (07) : A625 - A625
  • [38] Risk of Cardiovascular Disease according to Baseline LDL Cholesterol Level in Different Age Groups among 2 Million Diabetes Patients
    Lee, Won-Young
    Rhee, Eun-Jung
    Han, Kyungdo
    DIABETES, 2023, 72
  • [39] Cost-effectiveness of strict "get to goal" treatment directives in the treatment of younger patients with newly diagnosed type 2 diabetes mellitus (T2DM)
    Willis, M.
    Borg, S.
    Persson, U.
    Neslusan, C.
    VALUE IN HEALTH, 2007, 10 (06) : A260 - A260
  • [40] Cost-Effectiveness Analysis of Dapagliflozin Plus Standard Treatment for Patients With Type 2 Diabetes and High Risk of Cardiovascular Disease in China
    Huang, Kaiyu
    Wang, Yao
    Sun, Sijia
    Zhu, Qian
    Zhou, Weifeng
    Liu, Jiatao
    Zhu, Dongchun
    Xie, Xuefeng
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
12345